SYNCROVAX
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Mar 2026)
What this means for you
This application is over — abandoned 09 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97238141
- Mark type
- Stylized text
- Filed
- 25 Jan 2022
- Published for opposition
- 06 Dec 2022
- Abandoned
- 09 Mar 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
Owner
- Syncromune, Inc., Fort Lauderdale, FL, US
- Syncromune, Inc., Fort Lauderdale, FL, US
Prosecution history
- 09 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2025 — SOU EXTENSION 5 GRANTED
- 24 Jun 2025 — SOU EXTENSION 5 FILED
- 25 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jan 2025 — SOU EXTENSION 4 GRANTED
- 30 Jan 2025 — SOU EXTENSION 4 FILED
- 30 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2024 — SOU EXTENSION 3 GRANTED
- 27 Jun 2024 — SOU EXTENSION 3 FILED
- 27 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Feb 2024 — CORRECTED NOA E-MAILED